Non-surgical repair concept planning

Make the material-body interface visible before a construct is considered.

BioFit brings tissue conditions, delivery constraints, material compatibility and evidence maturity into one transparent review. It is designed to explain why a biohybrid construct is or is not a suitable research concept for a defined defect.

6
tissue categories
53
mapped anatomical locations
5
integration domains

What a biohybrid construct is

A temporary, biologically active bridge - not simply a material placed into a defect.

A biohybrid construct combines a structural base material with biological features and, where relevant, reinforcement. The design must remain stable in wet, moving, chemically active tissue long enough for the body's cells to attach, build new supporting tissue and gradually take over the repair.

01

Physical interface

Stiffness, porosity (internal open space), fluid swelling and planned support timing are compared with the target tissue. Actual load-sharing behaviour requires separate mechanical validation.

02

Biological integration

Cell attachment, extracellular-matrix signals, oxygen and nutrient transport, blood-vessel support where needed, and a controlled immune response are reviewed.

03

Chemical compatibility

Local pH, material breakdown products, released substances and the risk of harmful inflammation are reviewed before a score is calculated.

04

Delivery and fixation

Delivery route, time available before setting, wet-tissue adhesion and the ability to remain in place define whether a concept can reach and stay within the defect.

05

Remodelling

The material should gradually lose support as the body builds new tissue, allowing force to transfer without a sudden loss of strength.

Smart construct potential

Can a biohybrid construct report what is happening around it?

A construct can be designed to respond to its environment, but a response is not the same as communication. The profiles below separate material behaviour from sensing and from a real relay path for each available construct.

01

Responsive material

The material changes release, colour, shape or stiffness when local conditions change. This alone does not create a readable data signal.

02

Local sensing element

An optical, electrical or mechanical element converts a change such as pH, strain or moisture into a signal that can be measured.

03

Protected interface

The sensing element must be separated from cells and fluid where necessary, remain sterile, and keep working as the construct changes over time.

04

Reader or relay

A camera, external reader, passive wireless link or powered module captures the signal. Without this step, the construct cannot report in real time.

Construct-by-construct review

Smart upgrade potential across the BioFit library.

Filter by host tissue to compare what could be sensed, how a sensing layer could be added, and whether a published material precedent exists.

Loading smart material profiles...

Real manufactured reference examples

Context from real construct technologies.

These official manufacturer images are educational references. They are not presented as the experimental non-surgical constructs evaluated by BioFit, and product approval varies by country.

Manufactured MACI implant on a clinical tray
Reference technology

MACI cell-loaded membrane

A manufacturer example of a cell-based collagen membrane concept used to explain scaffold-plus-cell architecture.

Material source: a patient's own cartilage cells cultured on a porcine collagen membrane.
Manufacturer reference: Vericel, Cambridge, Massachusetts, USA.
Manufacturing country: not stated on this product page.
Image: Vericel / MACI | product source
Microscopy image of cultured chondrocytes attached to collagen fibres
Reference technology

MACI cell attachment micrograph

A manufacturer microscopy reference for explaining a cell-populated collagen interface.

Material source: the same MACI membrane uses the patient's cultured cartilage cells on porcine collagen.
Manufacturer reference: Vericel, Cambridge, Massachusetts, USA.
Manufacturing country: not stated on this product page.
Image: Vericel / MACI | product source
Chondro-Gide collagen membrane product
Reference technology

Chondro-Gide membrane

A collagen-based scaffold reference for discussing structural support and tissue interface design.

Material source: highly refined porcine collagen formed as a bilayer collagen I/III membrane.
Manufacturer reference: Geistlich Pharma AG, Switzerland.
Manufacturing country: confirm from product documentation.
Image: Geistlich | product source
Integra dermal regeneration template
Reference technology

Integra dermal template

A manufactured dermal scaffold example for discussing layered repair environments.

Material source: cross-linked bovine tendon collagen and chondroitin-6-sulfate, with a silicone outer layer.
Manufacturer reference: Integra LifeSciences, United States.
Manufacturing country: confirm from the product pack or IFU.
Image: Integra LifeSciences | product source

Case workspace

Build a structured repair brief.

Select the tissue and mapped body location first. BioFit then applies the correct tissue profile, delivery constraints and project eligibility gates before comparing construct concepts.

Loading the decision workspace...
01

Choose the target tissue

Start with the tissue family to load the correct biological and physical targets.

02

Locate the injury

Use the anatomy navigator or choose a full location from the directory.

Anterior skeletal anatomy reference
Selected site Available site

Atlas plates: public-domain human skeleton references. Markers record research-planning context, not patient-specific imaging.

The map records anatomical context for research planning. It is not diagnostic anatomy or patient-specific imaging.

03

Describe the defect

These inputs define the planning envelope; they do not replace clinical assessment.

Severity

Methodology and limits

Designed to be interrogated, not blindly trusted.

BioFit is a research prototype that applies disclosed targets, weights and project eligibility gates to a curated material library. It does not diagnose, prescribe, simulate a patient or predict treatment success.

  1. 1
    Validate the case input

    Tissue, injury, severity, location and optional defect dimension are checked before scoring.

  2. 2
    Apply hard gates

    Ineligible cases and route mismatches stop before a high compatibility score can override them.

  3. 3
    Show the evidence boundary

    Evidence maturity is reported separately from clinical effectiveness, which this tool does not claim.